#BEGIN_DRUGCARD DB02637

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C4H3O5

# Chemical_IUPAC_Name:
3-carboxy-3-oxopropanoate

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Oxaloacetate Ion

# HET_ID:
OAA

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C4H4O5/c5-2(4(8)9)1-3(6)7/h1H2,(H,6,7)(H,8,9)/p-1

# InChI_Key:
InChIKey=KHPXUQMNIQBQEV-UHFFFAOYSA-M

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2637

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
131.0636

# Molecular_Weight_Mono:
130.998048206

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1B8U

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.53

# Predicted_LogS:
-0.44

# Predicted_Water_Solubility:
5.42e+01 g/l

# Primary_Accession_No:
DB02637

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
3260017

# PubChem_Substance_ID:
46508157

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02406

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC(=O)C(=O)CC([O-])=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:20 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Not Available

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
CS

# Drug_Target_1_Gene_Sequence:
Not Available

# Drug_Target_1_General_Function:
Not Available

# Drug_Target_1_General_References:
Not Available

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
6969

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
Not Available

# Drug_Target_1_Name:
Citrate synthase, mitochondrial

# Drug_Target_1_Number_of_Residues:
0

# Drug_Target_1_PDB_ID:
Not Available

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
Not Available

# Drug_Target_1_Protein_Sequence:
Not Available

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
Not Available

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
O75390

# Drug_Target_1_SwissProt_Name:
CISY_HUMAN

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
Not Available

# Drug_Target_1_Transmembrane_Regions:
Not Available

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
AF109682

# Drug_Target_2_GenBank_ID_Protein:
4235484

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
mdh

# Drug_Target_2_Gene_Sequence:
>990 bp
ATGGCTAAAACCCCAATGCGTGTTGCTGTTACCGGCGCCGCCGGTCAGATTTGCTACTCA
CTGCTGTTTCGCATCGCCAACGGCGACATGCTCGGCAAGGATCAGCCAGTCATCTTGCAA
CTGCTTGAAATCCCGAACGAAAAAGCCCAGAAGGCCCTGCAAGGCGTGATGATGGAAATC
GACGATTGCGCCTTCCCTCTGCTGGCCGGCATGACCGCGCACGCTGATCCGATGACCGCA
TTCAAGGATGCCGACGTCGCCTTGCTGGTCGGCGCGCGTCCACGCGGCCCCGGCATGGAG
CGCAAGGATTTGCTGGAAGCCAATGCACAGATCTTCACGGTGCAAGGCAAGGCCATCGAT
GCCGTCGCGTCGCGCAACATCAAGGTGCTCGTGGTCGGCAATCCGGCCAACACCAACGCC
TATATCGCGATGAAATCGGCGCCTTCGCTGCCGGCCAAGAATTTCACCGCAATGCTGCGC
CTGGATCACAACCGCGCCTTGTCGCAAATTGCTGCCAAGACCGGCAAACCGGTATCGTCG
ATCGAAAAACTGTTCGTCTGGGGCAATCACTCGCCAACGATGTATGCCGACTACCGCTAC
GCGCAAATCGACGGCGCATCGGTCAAGGACATGATCAATGACGACGCATGGAACCGCGAC
ACGTTCTTGCCTACCGTGGGCAAGCGCGGCGCAGCCATCATCGATGCGCGCGGTGTATCG
TCGGCTGCCTCGGCTGCCAATGCGGCCATCGATCACATCCATGACTGGGTGCTGGGCACG
GCAGGCAAATGGACCACGATGGGCATCCCGTCCGATGGTTCGTATGGCATTCCGGAAGGG
GTGATCTTCGGCTTCCCGGTCACGACCGAAAACGGCGAATACAAGATCGTCCAAGGCTTG
AGCATTGACGCTTTCTCGCAAGAACGCATCAATGTCACACTGAACGAATTGCTGGAAGAG
CAGAACGGCGTCCAGCATCTGCTGGGCTAA

# Drug_Target_2_General_Function:
Energy production and conversion

# Drug_Target_2_General_References:
10206992	Kim SY, Hwang KY, Kim SH, Sung HC, Han YS, Cho Y: Structural basis for cold adaptation. Sequence, biochemical properties, and crystal structure of malate dehydrogenase from a psychrophile Aquaspirillium arcticum. J Biol Chem. 1999 Apr 23;274(17):11761-7.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3445

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
35252

# Drug_Target_2_Name:
Malate dehydrogenase

# Drug_Target_2_Number_of_Residues:
329

# Drug_Target_2_PDB_ID:
1B8V

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00056	Ldh_1_N
PF02866	Ldh_1_C

# Drug_Target_2_Protein_Sequence:
>Malate dehydrogenase
MAKTPMRVAVTGAAGQICYSLLFRIANGDMLGKDQPVILQLLEIPNEKAQKALQGVMMEI
DDCAFPLLAGMTAHADPMTAFKDADVALLVGARPRGPGMERKDLLEANAQIFTVQGKAID
AVASRNIKVLVVGNPANTNAYIAMKSAPSLPAKNFTAMLRLDHNRALSQIAAKTGKPVSS
IEKLFVWGNHSPTMYADYRYAQIDGASVKDMINDDAWNRDTFLPTVGKRGAAIIDARGVS
SAASAANAAIDHIHDWVLGTAGKWTTMGIPSDGSYGIPEGVIFGFPVTTENGEYKIVQGL
SIDAFSQERINVTLNELLEEQNGVQHLLG

# Drug_Target_2_Reaction:
(S)-malate + NAD+ = oxaloacetate + NADH + H+

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Catalyzes the reversible oxidation of malate to oxaloacetate

# Drug_Target_2_SwissProt_ID:
Q9ZF99

# Drug_Target_2_SwissProt_Name:
MDH_AQUAR

# Drug_Target_2_Synonyms:
EC 1.1.1.37

# Drug_Target_2_Theoretical_pI:
6.25

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Cytoplasm

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
SPR

# Drug_Target_3_GenBank_ID_Gene:
M76231

# Drug_Target_3_GenBank_ID_Protein:
338021

# Drug_Target_3_GeneCard_ID:
SPR

# Drug_Target_3_Gene_Name:
SPR

# Drug_Target_3_Gene_Sequence:
>786 bp
ATGGAGGGCGGGCTGGGGCGTGCTGTGTGCTTGCTGACCGGGGCCTCCCGCGGCTTCGGC
CGGACGCTGGCCCCGCTCCTGGCCTCGCTGCTGTCGCCCGGCTCCGTGCTTGTCCTTAGC
GCCCGCAACGACGAGGCACTGCGCCAGCTGGAGGCCGAGCTGGGCGCCGAGCGGTCTGGC
CTGCGCGTGGTGCGGGTGCCCGCCGACCTGGGCGCCGAGGCCGGCTTGCAGCAGCTGCTC
GGCGCCCTGCGCGAGCTCCCCCGGCCCAAGGGGCTGCAGCGACTGCTGCTTATCAACAAC
GCGGGCTCTCTTGGGGATGTGTCCAAAGGCTTCGTGGACCTGAGTGACTCCACTCAAGTG
AACAACTACTGGGCACTGAACTTGACCTCCATGCTCTGCCTGACTTCCAGCGTCCTGAAG
GCCTTCCCGGACAGTCCTGGCCTCAACAGAACCGTGGTTAACATCTCGTCCCTCTGTGCC
CTGCAACCTTTCAAAGGCTGGGCGCTGTACTGTGCAGGAAAGGCTGCTCGTGATATGCTG
TTCCAGGTCCTGGCGCTGGAGGAACCTAATGTGAGGGTGCTGAACTATGCCCCAGGTCCT
CTGGACACAGACATGCAGCAGTTGGCCCGGGAGACCTCCGTGGACCCAGACATGCGAAAA
GGGCTGCAGGAGCTGAAGGCAAAGGGGAAGCTGGTGGATTGCAAGGTGTCAGCCCAGAAA
CTGCTGAGCTTACTGGAAAAGGACGAGTTCAAGTCTGGAGCCCACGTGGACTTCTATGAC
AAATAA

# Drug_Target_3_General_Function:
Lipid transport and metabolism

# Drug_Target_3_General_References:
11825621	Fujimoto K, Takahashi SY, Katoh S: Mutational analysis of sites in sepiapterin reductase phosphorylated by Ca2+/calmodulin-dependent protein kinase II. Biochim Biophys Acta. 2002 Jan 31;1594(1):191-8.
1883349	Ichinose H, Katoh S, Sueoka T, Titani K, Fujita K, Nagatsu T: Cloning and sequencing of cDNA encoding human sepiapterin reductase--an enzyme involved in tetrahydrobiopterin biosynthesis. Biochem Biophys Res Commun. 1991 Aug 30;179(1):183-9.
8440319	Maier J, Schott K, Werner T, Bacher A, Ziegler I: Detection of a novel sepiapterin reductase mRNA: assay of mRNA in various cells and tissues of various species. Exp Cell Res. 1993 Feb;204(2):217-22.

# Drug_Target_3_HGNC_ID:
HGNC:11257

# Drug_Target_3_HPRD_ID:
01632

# Drug_Target_3_ID:
1124

# Drug_Target_3_Locus:
2p14-p12

# Drug_Target_3_Molecular_Weight:
28049

# Drug_Target_3_Name:
Sepiapterin reductase

# Drug_Target_3_Number_of_Residues:
261

# Drug_Target_3_PDB_ID:
1Z6Z

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00106	adh_short

# Drug_Target_3_Protein_Sequence:
>Sepiapterin reductase
MEGGLGRAVCLLTGASRGFGRTLAPLLASLLSPGSVLVLSARNDEALRQLEAELGAERSG
LRVVRVPADLGAEAGLQQLLGALRELPRPKGLQRLLLINNAGSLGDVSKGFVDLSDSTQV
NNYWALNLTSMLCLTSSVLKAFPDSPGLNRTVVNISSLCALQPFKGWALYCAGKAARDML
FQVLALEEPNVRVLNYAPGPLDTDMQQLARETSVDPDMRKGLQELKAKGKLVDCKVSAQK
LLSLLEKDEFKSGAHVDFYDK

# Drug_Target_3_Reaction:
7,8-dihydrobiopterin + NADP+ = sepiapterin + NADPH + H+

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Catalyzes the final one or two reductions in tetra- hydrobiopterin biosynthesis to form 5,6,7,8-tetrahydrobiopterin

# Drug_Target_3_SwissProt_ID:
P35270

# Drug_Target_3_SwissProt_Name:
SPRE_HUMAN

# Drug_Target_3_Synonyms:
EC 1.1.1.153
SPR

# Drug_Target_3_Theoretical_pI:
8.19

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Not Available

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
AJ606310

# Drug_Target_4_GenBank_ID_Protein:
38304072

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
Not Available

# Drug_Target_4_Gene_Sequence:
>1560 bp
ATGAGTCCGCGAGAAATTGAGGTTTCCGAGCCGCGCGAGGTTGGTATCACCGAGCTCGTG
CTGCGCGATGCCCATCAGAGCCTGATGGCCACACGAATGGCAATGGAAGACATGGTCGGC
GCCTGTGCAGACATTGATGCTGCCGGGTACTGGTCAGTGGAGTGTTGGGGTGGTGCCACG
TATGACTCGTGTATCCGCTTCCTCAACGAGGATCCTTGGGAGCGTCTGCGCACGTTCCGC
AAGCTGATGCCCAACAGCCGTCTCCAGATGCTGCTGCGTGGCCAGAACCTGCTGGGTTAC
CGCCACTACAACGACGAGGTCGTCGATCGTTTCGTCGACAAGTCCGCTGAGAACGGCATG
GACGTGTTCCGTGTCTTCGACGCCATGAATGATCCCCGCAATATGGCGCACGCCATGGCT
GCCGTCAAGAAGGCCGGCAAGCACGCGCAGGGCACCATTTGCTACACGATCAGCCCGGTC
CACACCGTTGAGGGCTATGTCAAGCTTGCTGGTCAGCTGCTCGACATGGGTGCTGATTCC
ATCGCCCTGAAGGACATGGCCGCCCTGCTCAAGCCGCAGCCGGCCTACGACATCATCAAG
GCCATCAAGGACATACGGCCAGAAGACGCAGATCAACCTGCACTGCACTCCACCACGGGT
GTCACCGAGGTCTCCCTCATGAAGGCCATCGAGGCCGGCGTCGACACCGCCATCTCGTCC
ATGTCGCTCGGCCCGGGCCACAACCCCACCGAGTCGGTTGCCGAGATGCTCGAGGGCACC
GGGTACACCACCAACCTTGACTACGATCGCCTGCACAAGATCCGCGATCACTTCAAGGCC
ATCCGCCCGAAGTACAAGAAGTTCGAGTCGAAGACGCTTGTCGACACCTCGATCTTCAAG
TCGCAGATCCCCGGCGGCATGCTGTCCAACATGGAGTCGCAGCTGCGCGCCCAGGGCGCC
GAGGACAAGATGGACGAGGTCATGGCAGAGGTGCCGCGCGTCCGAAGGCCGGCGCCGGTT
TTCCCCGCCCCTGGTCACCCCGTCCAGCCAGATCGTCGGCACGCAGGCCTGTTCAACGTG
ATGATGGGCGAGTACAAGAGGATGACCGGCGAGTTCGCAGATATCATGCTCGGCTACTAC
GGCGCCACGCCGGCCGATCGCGATCCGAAGTGGTCAGTTGGCGAGGAGCATCGCAGAGCG
ATCACCCAGCGCCCGGCCGATCACGATCCGAAGGTGGTCAAGTTGGCCGAGGAGCAGTCC
GGCAAGAAGCCGATCACCCAGCGCCCGGCCGATCTGCTGCCCCCCGAGTGGGAGGAGCAG
TCCAAGGAGCCGCGCCCTAAGGGCTTCAACGGCACCGACGAGGACGTGCTCACCTATGCA
CTGTTCCCGCAGGTCGCTCCGGTCTTCTTCGAGAGTCGGCCGAGGGCCGCAGAGGTGGCT
CTCACCGATGCCCAGCTGAAGGCCGAGGCGAGGGCGACGAGAAGTGTCGCCGTGGCCGGT
CCCGTCACCTACAACGTGAACGTGCGGAACCGTCCGCAAGTCACCGTTCAGCAGGCGTGA

# Drug_Target_4_General_Function:
Energy production and conversion

# Drug_Target_4_General_References:
8365490	Thornton CG, Kumar GK, Shenoy BC, Haase FC, Phillips NF, Park VM, Magner WJ, Hejlik DP, Wood HG, Samols D: Primary structure of the 5 S subunit of transcarboxylase as deduced from the genomic DNA sequence. FEBS Lett. 1993 Sep 13;330(2):191-6.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
2983

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
55650

# Drug_Target_4_Name:
Methylmalonyl-CoA carboxyltransferase 5S subunit

# Drug_Target_4_Number_of_Residues:
505

# Drug_Target_4_PDB_ID:
1RQE

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF00682	HMGL-like
PF02436	PYC_OADA

# Drug_Target_4_Protein_Sequence:
>Methylmalonyl-CoA carboxyltransferase 5S subunit
MSPREIEVSEPREVGITELVLRDAHQSLMATRMAMEDMVGACADIDAAGYWSVECWGGAT
YDSCIRFLNEDPWERLRTFRKLMPNSRLQMLLRGQNLLGYRHYNDEVVDRFVDKSAENGM
DVFRVFDAMNDPRNMAHAMAAVKKAGKHAQGTICYTISPVHTVEGYVKLAGQLLDMGADS
IALKDMAALLKPQPAYDIIKAIKDTYGQKTQINLHCHSTTGVTEVSLMKAIEAGVDVVDT
AISSMSLGPGHNPTESVAEMLEGTGYTTNLDYDRLHKIRDHFKAIRPKYKKFESKTLVDT
SIFKSQIPGGMLSNMESQLRAQGAEDKMDEVMAEVPRVRKAAGFPPLVTPSSQIVGTQAV
FNVMMGEYKRMTGEFADIMLGYYGASPADRDPKVVKLAEEQSGKKPITQRPADLLPPEWE
KQSKEAATLKGFNGTDEDVLTYALFPQVAPVFFEHRAEGPHSVALTDAQLKAEAEGDEKS
LAVAGPVTYNVNVGGTVREVTVQQA

# Drug_Target_4_Reaction:
(S)-methylmalonyl-CoA + pyruvate = propanoyl-CoA + oxaloacetate

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
The 5S subunit specifically catalyzes the transfer of the carboxyl group from biotin of the 1.3S subunit to pyruvate to form oxaloacetate and 1.3S biotin

# Drug_Target_4_SwissProt_ID:
Q70AC7

# Drug_Target_4_SwissProt_Name:
5S_PROFR

# Drug_Target_4_Synonyms:
EC 2.1.3.1
Transcarboxylase 5S subunit

# Drug_Target_4_Theoretical_pI:
5.51

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
Not Available

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
AE000513

# Drug_Target_5_GenBank_ID_Protein:
Not Available

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
DR_1240

# Drug_Target_5_Gene_Sequence:
>855 bp
TCAGGCTTCGTGGCTCAGCAGAGTGCGGGCTTTGGCGAGCATCGGCTCGTCCACCATCTG
CCCCTCAAAACTAAAGGCGCCGTGGCCCCGTTGCGCGGCGGCGGCGGCAGCATCGAGCAG
GGCGCGGGCACGGGCACGGTCGGCCTCGGTCGGCCCGAAATATTCGTGGGCAAGGGCTAC
CTGCGCCGGATGGATGCAGAGTTTGCCGCTGTAGCCCAGGGCGCGGCCCTGCTCGGCGTC
GGCGCGGAAGGTCTCGGGGTCGTTGAGTGCCGTCACCACGATGTCGAGCGCCGCCACTCC
GGTCAGTCGCGCCGCGAGCGCCACCTGTGAGCGGGCGTAGAGGACTTCCAGTCCCCCCGG
CGTGCGCTTGCCGCCCAGGTCAGTGGTGTAGTCCTCGGCACCGAAATAAGCCCAGGCGAC
CTCGGGCACCTCCATGATTTCGCGGGCGTTCCAGACCCCGGCTCCGGTTTCCAGACCCGC
CAGGATGGGCAGCGGCAGGCTGCGCTCCTGGAGCATCTGCGCCACCTGCCGCGCCTCAGC
GCCCATTTCCAGTTTGGGAACCACCACGCCGCTCAGTTCGGGGGTCAGCACACTCAGGTC
GTCCTCGAAATACGGCGAGTGCAGCGCATTGACCCGCACGAACACGGCGAGGTGCGGTGC
GGCGGCAATGAGGTCACGGGCCGCGTCGTGCGCCACTGGGCGGGCGGCGGCCTTCGCCTC
GGCGGTGCCCGGCACGGCGTCTTCGAGGTCGATCACCACCGCGTCCGGGGCCGAGCGCGG
CAATTTGGCAATCAGGTCGGCACGGTTCCCCGGCGCGAACAGCACCGAGCGGAGCAGAGC
AGGAGGGGCATTCAC

# Drug_Target_5_General_Function:
Involved in citrate (pro-3S)-lyase activity

# Drug_Target_5_General_References:
10567266	White O, Eisen JA, Heidelberg JF, Hickey EK, Peterson JD, Dodson RJ, Haft DH, Gwinn ML, Nelson WC, Richardson DL, Moffat KS, Qin H, Jiang L, Pamphile W, Crosby M, Shen M, Vamathevan JJ, Lam P, McDonald L, Utterback T, Zalewski C, Makarova KS, Aravind L, Daly MJ, Minton KW, Fleischmann RD, Ketchum KA, Nelson KE, Salzberg S, Smith HO, Venter JC, Fraser CM: Genome sequence of the radioresistant bacterium Deinococcus radiodurans R1. Science. 1999 Nov 19;286(5444):1571-7.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
4781

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
29980

# Drug_Target_5_Name:
Citrate lyase beta subunit-like protein

# Drug_Target_5_Number_of_Residues:
284

# Drug_Target_5_PDB_ID:
1SGJ

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF03328	HpcH_HpaI

# Drug_Target_5_Protein_Sequence:
>Citrate lyase beta subunit-like protein
MNAPPALLRSVLFAPGNRADLIAKLPRSAPDAVVIDLEDAVPGTAEAKAAARPVAHDAAR
DLIAAAPHLAVFVRVNALHSPYFEDDLSVLTPELSGVVVPKLEMGAEARQVAQMLQERSL
PLPILAGLETGAGVWNAREIMEVPEVAWAYFGAEDYTTDLGGKRTPGGLEVLYARSQVAL
AARLTGVAALDIVVTALNDPETFRADAEQGRALGYSGKLCIHPAQVALAHEYFGPTEADR
ARARALLDAAAAAAQRGHGAFSFEGQMVDEPMLAKARTLLSHEA

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
May play a role in fatty acid biosynthesis (Potential)

# Drug_Target_5_SwissProt_ID:
Q9RUZ0

# Drug_Target_5_SwissProt_Name:
CITEL_DEIRA

# Drug_Target_5_Synonyms:
EC 4.1.-.-

# Drug_Target_5_Theoretical_pI:
4.91

# Drug_Target_5_Transmembrane_Regions:
None

#END_DRUGCARD DB02637
